Live feed16:05:00·908dPRReleasevia QuantisnowCrinetics Announces Positive Initial Findings from Ongoing Open-Label Phase 2 Study of Paltusotine for the Treatment of Carcinoid SyndromeByQuantisnow·Wall Street's wire, on your screen.CRNX· Crinetics Pharmaceuticals Inc.Health Care
